Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct - Dividend Reinvestment

NAV
returns change indicator
76.4361
as on 05 Jun 2020, 10:20 PM
0.0619(0.08%)
Last Change
loaderloader

Start SIP in this Mutual Fund

Min SIP Amount
100
Suggested Date
8th of Every Month

Investment Performance

would have given a return of
110,871
star
121,647
star
154,131
star
158,217
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
58,217
Profit (absolute return)
58.22%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
18.59%
In the last 6 months
27.01%
In the last 1 year
34.06%
In the last 3 years
58.22%
In the last 5 years
53.28%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Nippon India Pharma Fund Direct - Dividend Reinvestment
Nippon India Pharma Fund Direct - Dividend Reinvestment
as of 30 Apr 2020, 05:30 AM
2,850.69 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
1.30%
Expense Ratio
Plan
Dividend
3.47%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document

Sectors Holding in this Mutual Fund

as on 30 Apr 2020
Sort By
Healthcare
96.48%
2,750.35 Cr
Cash Holding
3.47%
98.92 Cr

Companies Holding in this Mutual Fund

as on 30 Apr 2020
Sort By
Aurobindo Pharma Ltd.
10.98%
313.01 Cr
Dr. Reddy's Laboratories Ltd.
10.36%
295.33 Cr
Sun Pharmaceutical Inds. Ltd.
10.27%
292.77 Cr
Divi's Laboratories Ltd.
9.00%
256.56 Cr
Cipla Ltd.
7.86%
224.06 Cr
Lupin Ltd.
7.33%
208.96 Cr
Syngene International Ltd.
4.86%
138.54 Cr
Sanofi India Ltd.
4.77%
135.98 Cr
Fortis Healthcare (India) Ltd
4.72%
134.55 Cr
Thyrocare Technologies Ltd.
4.53%
129.14 Cr
View All
View All

About Nippon India Pharma Fund Direct - Dividend Reinvestment

Nippon India Pharma Fund Direct - Dividend Reinvestment is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹2,850.69 Crores and the latest NAV decalared is ₹76.436 as on 06 Jun 2020 at 4:50 pm.
Nippon India Pharma Fund Direct - Dividend Reinvestment scheme return performance in last 1 year is 34.06%, in last 3 years is 58.22% and 191.81% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:2,850.69 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
178,238.25 Cr
AUM
192
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : 022-68334800 / 18602660111
Fax : 022-33037662